Stem Cells: Revolutionizing Autoimmune Treatment with Kyverna & ElevateBio
![Kyverna Therapeutics](https://nationalstemcelltherapy.com/wp-content/uploads/2023/09/Kyverna_Therapeutics___Logo-1024x537.jpg)
Kyverna Therapeutics, a clinical-stage cell therapy company, and ElevateBio, a technology-driven company specializing in cell and gene therapies, have announced a partnership aimed at advancing the development and manufacturing processes for Kyverna’s Ingenui-T-derived chimeric antigen receptor (CAR) T-cell therapies. The Ingenui-T platform, developed by Kyverna, is optimized for autologous CAR-T cell manufacturing for autoimmune diseases, […]